Fp Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fisher & Paykel Healthcare Ltd (FPH)
Discover who owns Fisher&Paykel Healthcare. Access the ownership overview, view the top Fisher&Paykel Healthcare shareholders, institutional holders, and leading mutual fund investors. Understand the key stakeholders and the distribution of FPH shares among major financial entities.
36.76
-0.22(-0.59%)
Closed·
Fair Value
An estimate of a Fisher & Paykel Healthcare Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
36.53
36.97
52 wk Range
31.27
39.50
FPH Scorecard
Full Analysis
Has raised its dividend for 11 consecutive years
FPH is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Fisher & Paykel Healthcare Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
36.5336.97
52 wk Range
31.2739.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.35%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.35%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
FPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Fisher & Paykel Healthcare Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
35.52
Downside
-3.38%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
- Fp Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Fp Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Fp Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Fp Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Fisher & Paykel Healthcare Ltd Company Profile
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Compare FPH to Peers and Sector
Metrics to compare | FPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 57.5x | 17.8x | −0.5x | |
PEG Ratio | 0.31 | 0.24 | 0.00 | |
Price/Book | 11.5x | 2.4x | 2.6x | |
Price / LTM Sales | 10.7x | 5.5x | 3.2x | |
Upside (Analyst Target) | −2.0% | 25.6% | 42.0% | |
Fair Value Upside | Unlock | 9.8% | 6.6% | Unlock |
Analyst Ratings
3 Buy
6 Hold
3 Sell
Ratings:
12 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 35.52
(-3.38% Downside)
Earnings
Latest Release
May 27, 2025
EPS / Forecast
0.38 / 0.3603
Revenue / Forecast
1.07B / 1.05B
People Also Watch
FAQ
What Stock Exchange Does Fisher & Paykel Healthcare Ltd Trade On?
Fisher & Paykel Healthcare Ltd is listed and trades on the New Zealand Exchange stock exchange.
What Is the Stock Symbol for Fisher & Paykel Healthcare Ltd?
The stock symbol for Fisher & Paykel Healthcare Ltd is "FPH."
What Is the Fisher & Paykel Healthcare Ltd Market Cap?
As of today, Fisher & Paykel Healthcare Ltd market cap is 21.34B.
What Is Fisher & Paykel Healthcare Ltd's Earnings Per Share (TTM)?
The Fisher & Paykel Healthcare Ltd EPS (TTM) is 0.64.
When Is the Next Fisher & Paykel Healthcare Ltd Earnings Date?
Fisher & Paykel Healthcare Ltd will release its next earnings report on 02 Sept 2025.
From a Technical Analysis Perspective, Is FPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Fisher & Paykel Healthcare Ltd Stock Split?
Fisher & Paykel Healthcare Ltd has split 1 times.
How Many Employees Does Fisher & Paykel Healthcare Ltd Have?
Fisher & Paykel Healthcare Ltd has 7412 employees.
What is the current trading status of Fisher & Paykel Healthcare Ltd (FPH)?
As of 30 Jul 2025, Fisher & Paykel Healthcare Ltd (FPH) is trading at a price of 36.76, with a previous close of 36.98. The stock has fluctuated within a day range of 36.53 to 36.97, while its 52-week range spans from 31.27 to 39.50.
What Is Fisher & Paykel Healthcare Ltd (FPH) Price Target According to Analysts?
The average 12-month price target for Fisher & Paykel Healthcare Ltd is NZD35.51667, with a high estimate of NZD40.9 and a low estimate of NZD27. 3 analysts recommend buying the stock, while 3 suggest selling, leading to an overall rating of Neutral. The stock has an -3.38% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.